Featured Research

from universities, journals, and other organizations

'Vicious Cycle' Of Protein Formation Involved In Parkinson's Disease

Date:
June 30, 2005
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
Researchers at UT Southwestern Medical Center have discovered a mechanism that causes a protein to clump together in brain cells of people with Parkinson's disease, pointing toward a possible treatment for the condition.

UT Southwestern's Dr. Chang-Wei Liu (left), research fellow in physiology, Dr. Philip Thomas, professor of physiology, and student research assistant Karen Lewis discovered that a cascade of protein reactions takes place in neurons involved with Parkinson's disease.
Credit: Image courtesy of University Of Texas Southwestern Medical Center At Dallas

DALLAS - June 21, 2005 - Researchers at UT Southwestern Medical Center have discovered a mechanism that causes a protein to clump together in brain cells of people with Parkinson's disease, pointing toward a possible treatment for the condition.

The protein clumping is part of a "vicious cycle," the researchers said. As the proteins cluster, they inhibit an enzyme that normally breaks them down, leading to the formation of even more masses.

"It's a disease involving accumulation of a protein in an aberrant form," said Dr. Philip Thomas, professor of physiology at UT Southwestern and senior author of the study. The research, available online, was published in the June 17 issue of The Journal of Biological Chemistry.

The findings have parallels to other diseases in which protein clusters form in and around nerves, such as Huntington's and Alzheimer's disease.

The culprit in Parkinson's is the protein alpha-synuclein, which normally appears in a long, folded form in cells. It's known to be linked to the disease because mutations in it cause rare, inherited cases of early-onset Parkinson's.

Normally, if a cell becomes stressed, alpha-synuclein unfolds, and an enzyme degrades it completely into harmless bits to prevent the clumping. In Parkinson's patients, however, some of the degrading enzyme malfunctions and creates truncated fragments of alpha-synuclein rather than the harmless bits.

UT Southwestern researchers found that these truncated fragments act like "seeds," encouraging the unfolded form of alpha-synuclein to gather around them. It doesn't take much - just a few molecules of the truncated fragments - to activate this process. Eventually, the cluster is big enough to form a structure called a fibril.

The two forms of the enzyme are usually in balance, with the normal activity outperforming the malicious activity, Dr. Thomas said.

But when the system goes out of balance, the fibrils suppress the normally functioning enzyme, preventing it from fully breaking down the unfolded alpha-synuclein, resulting in even more of the protein being available to form clumps. The clumps also alter the structure of the enzyme in such a way that it produces even more seed fragments. This leads to the formation of more clumps, and so on.

Scientists are still debating which form of the alpha-synuclein protein actually damages the cells, said Dr. Chang-Wei Liu, research fellow in physiology at UT Southwestern and lead author of the study. It could be the mature fibril, or one of the intermediate forms that appears during the degradation process, he said.

Future research may involve uncovering methods to inhibit just the malicious form of the enzyme, while leaving the functions of the normal enzyme unaffected, Dr. Thomas said. Inhibiting only one form is vital, because the normal enzyme is necessary for cells to survive.

Still, the finding reported in The Journal of Biological Chemistry "gives us clues about potential new treatment avenues," he said.

Other UT Southwestern authors of the study are Karen Lewis, student research assistant in physiology, and Dr. George DeMartino, professor of physiology. Researchers at the University of Pennsylvania School of Medicine also contributed.

The work was funded by the National Institutes of Health and the Parkinson's Disease Foundation.


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "'Vicious Cycle' Of Protein Formation Involved In Parkinson's Disease." ScienceDaily. ScienceDaily, 30 June 2005. <www.sciencedaily.com/releases/2005/06/050630060745.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2005, June 30). 'Vicious Cycle' Of Protein Formation Involved In Parkinson's Disease. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2005/06/050630060745.htm
University Of Texas Southwestern Medical Center At Dallas. "'Vicious Cycle' Of Protein Formation Involved In Parkinson's Disease." ScienceDaily. www.sciencedaily.com/releases/2005/06/050630060745.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins